Precision for Medicine President Chad Clark speaks with Alex Philippides of Clinical OMICs to discuss Precision’s European expansion. With the goal of better serving developers of cancer treatments worldwide, Clark outlines some of the challenges of conducting immune-oncology studies and defines some of the solutions that Precision now offers in the US and EU.
To read the complete article, please click here.